role of rebates in glp-1 pbm decisions The Pharmacy Benefits The PBM Business Model |
Description
Understanding personal risk factors and medication characteristics can support safer treatment
GLP-1 medications like semaglutide work through a different pathway to reduce appetite and support weight loss
Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA
Experience a fresher, delicate state with enhanced comfort
This means that its natural effect in the joint is likely to be limited
Discover essential nutrition hacks for GLP-1 users
